Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia?
It has been suggested that the underactivity of mesial frontal structures induced by dopamine depletion could constitute one of the main substrates underlying akinesia in Parkinson's disease. Functional imaging and movement-related potential recordings indicate an implication of the frontal lobes in this pathological process, but the question has not yet been investigated at a cellular level using single unit recording. We therefore compared neuronal activity in both the presupplementary motor area (pre-SMA) and the supplementary motor area proper (SMAp) of the Macaca mulatta monkey during a delayed motor task, before and after MPTP treatment. In the pre-SMA, which receives strong inputs from the prefrontal cortex, the baseline firing frequency and the percentage of neurons responding to visual instruction cues decreased in lesioned monkeys. In the SMAp, which sends direct outputs to the primary motor cortex, not only was the response to visual cues impaired, but the percentage of SMAp neurons responding to intracortical microstimulation fell and the threshold of response rose. Neuronal activity after the Go signal diminished sharply in both structures in the symptomatic animal and the discharge pattern became more irregular; in the SMAp neuronal activity remained modified longer. Most of these changes could already be observed in the presymptomatic animal presenting no clinical signs of parkinsonism. These data would indicate that, at the moment when dopamine depletion has impaired the ability of cortical neurons to operate the focused selection of incoming information giving instructions for movement, pre-SMA and SMAp neurons are also in a state of severe hypoactivity. The conjunction of these phenomena could play a critical role in the genesis of akinesia.
Escola
L
L
Laboratoire de Neurophysiologie, Université Victor Segalen, Bordeaux, France.
Michelet
Th
T
Macia
F
F
Guehl
D
D
Bioulac
B
B
Burbaud
P
P
D000818:Animals; D018492:Dopamine Antagonists / Q000494:pharmacology; D004334:Drug Administration Schedule; D004558:Electric Stimulation; D005260:Female; D020267:MPTP Poisoning; D008252:Macaca fascicularis; D008606:Mental Processes / Q000187:drug effects*; D008636:Mesencephalon / Q000201:enzymology; D023421:Models, Animal; D009044:Motor Cortex / Q000503:physiopathology*; D009474:Neurons / Q000201:enzymology / Q000502:physiology*; D009483:Neuropsychological Tests; D020734:Parkinsonian Disorders / Q000523:psychology*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D018492:Dopamine Antagonists; D014446:Tyrosine 3-Monooxygenase